Literature DB >> 11924040

Neuroendocrine dysregulation in primary insomnia.

A Rodenbeck1, G Hajak.   

Abstract

Recent research has pointed to a functional link between stress, disturbed sleep, psychiatric disorders, ageing, and neuroendocrine dysfunctions. In particular, increased activation of the hypothalamic-pituitary-adrenal (HPA) axis--expressed as elevated plasma cortisol levels--was shown in physiological ageing and patients with psychiatric disorders. We found increased evening and nocturnal plasma cortisol concentrations in patients with primary insomnia. Considering that both ageing and psychiatric disorders are commonly associated with sleep disturbances, our results implicate that elevated cortisol concentrations are a rather unspecific feature of disturbed sleep. Furthermore, our data revealed a strong positive correlation between evening cortisol secretion and the number of nocturnal awakenings in both insomniac patients and controls. Since nocturnal exposure to increased HPA activity promotes sleep fragmentation even in healthy controls, increased evening cortisol levels may be a crucial factor in inducing and maintaining sleep disturbances. We therefore propose a model of HPA dysregulation in insomnia. This model is based on the arousal theory of insomnia and the strong correlation between evening cortisol secretion and sleep fragmentation as a pathophysiological mechanism of a vicious cycle of insomnia. In patients with long-lasting insomniac complaints we found decreased nocturnal plasma melatonin levels thereby indicating a labilisation of circadian rhythm functions. Taken together, the neuroendocrine dysregulation seems to be more expressed in chronic insomnia than in acute insomnia and may be a contributing factor in maintaining disturbed sleep.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11924040

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  27 in total

Review 1.  Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.

Authors:  George F Koob; Ian M Colrain
Journal:  Neuropsychopharmacology       Date:  2019-06-24       Impact factor: 7.853

2.  Oxytocin, social support, and sleep quality in low-income minority women living with HIV.

Authors:  Erin M Fekete; Julia Seay; Michael H Antoni; Armando J Mendez; Mary Ann Fletcher; Angela Szeto; Neil Schneiderman
Journal:  Behav Sleep Med       Date:  2013-06-25       Impact factor: 2.964

3.  Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activity.

Authors:  Marcella Balbo; Rachel Leproult; Eve Van Cauter
Journal:  Int J Endocrinol       Date:  2010-06-09       Impact factor: 3.257

4.  EEG spectral analysis in primary insomnia: NREM period effects and sex differences.

Authors:  Daniel J Buysse; Anne Germain; Martica L Hall; Douglas E Moul; Eric A Nofzinger; Amy Begley; Cindy L Ehlers; Wesley Thompson; David J Kupfer
Journal:  Sleep       Date:  2008-12       Impact factor: 5.849

5.  Insomnia Severity, Subjective Sleep Quality, and Risk for Obstructive Sleep Apnea in Veterans With Gulf War Illness.

Authors:  Linda L Chao; Linda R Abadjian; Iva L Esparza; Rosemary Reeb
Journal:  Mil Med       Date:  2016-09       Impact factor: 1.437

Review 6.  Marital quality and the marital bed: examining the covariation between relationship quality and sleep.

Authors:  Wendy M Troxel; Theodore F Robles; Martica Hall; Daniel J Buysse
Journal:  Sleep Med Rev       Date:  2007-10       Impact factor: 11.609

7.  The acute and post-discontinuation effects of a glucocorticoid receptor (GR) antagonist probe on sleep and the HPA axis in chronic insomnia: a pilot study.

Authors:  Theresa Buckley; Vandana Duggal; Alan F Schatzberg
Journal:  J Clin Sleep Med       Date:  2008-06-15       Impact factor: 4.062

8.  Insomnia and sleep duration as mediators of the relationship between depression and hypertension incidence.

Authors:  James E Gangwisch; Dolores Malaspina; Kelly Posner; Lindsay A Babiss; Steven B Heymsfield; J Blake Turner; Gary K Zammit; Thomas G Pickering
Journal:  Am J Hypertens       Date:  2009-11-05       Impact factor: 2.689

9.  The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks.

Authors:  A Rodenbeck; S Cohrs; W Jordan; G Huether; E Rüther; G Hajak
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

Review 10.  To breathe, perchance to sleep: sleep-disordered breathing and chronic insomnia among trauma survivors.

Authors:  Barry Krakow; Dominic Melendrez; Teddy D Warner; Richard Dorin; Ronald Harper; Michael Hollifield
Journal:  Sleep Breath       Date:  2002-12       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.